BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 7596436)

  • 1. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium.
    Fong GH; Rossant J; Gertsenstein M; Breitman ML
    Nature; 1995 Jul; 376(6535):66-70. PubMed ID: 7596436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development.
    Breier G; Clauss M; Risau W
    Dev Dyn; 1995 Nov; 204(3):228-39. PubMed ID: 8573716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
    Shibuya M; Seetharam L; Ishii Y; Sawano A; Gotoh N; Matsushime H; Yamaguchi S
    Princess Takamatsu Symp; 1994; 24():162-70. PubMed ID: 8983073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1).
    Yamane A; Seetharam L; Yamaguchi S; Gotoh N; Takahashi T; Neufeld G; Shibuya M
    Oncogene; 1994 Sep; 9(9):2683-90. PubMed ID: 8058332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells.
    Ahmed A; Dunk C; Kniss D; Wilkes M
    Lab Invest; 1997 Jun; 76(6):779-91. PubMed ID: 9194854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.
    Ferrara N; Carver-Moore K; Chen H; Dowd M; Lu L; O'Shea KS; Powell-Braxton L; Hillan KJ; Moore MW
    Nature; 1996 Apr; 380(6573):439-42. PubMed ID: 8602242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
    Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C
    EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
    Seetharam L; Gotoh N; Maru Y; Neufeld G; Yamaguchi S; Shibuya M
    Oncogene; 1995 Jan; 10(1):135-47. PubMed ID: 7824266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.
    Carmeliet P; Ferreira V; Breier G; Pollefeyt S; Kieckens L; Gertsenstein M; Fahrig M; Vandenhoeck A; Harpal K; Eberhardt C; Declercq C; Pawling J; Moons L; Collen D; Risau W; Nagy A
    Nature; 1996 Apr; 380(6573):435-9. PubMed ID: 8602241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
    Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G
    Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro.
    Grosskreutz CL; Anand-Apte B; Dupláa C; Quinn TP; Terman BI; Zetter B; D'Amore PA
    Microvasc Res; 1999 Sep; 58(2):128-36. PubMed ID: 10458928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the VEGF binding site on the Flt-1 receptor.
    Herley MT; Yu Y; Whitney RG; Sato JD
    Biochem Biophys Res Commun; 1999 Sep; 262(3):731-8. PubMed ID: 10471394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
    Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells.
    Barleon B; Siemeister G; Martiny-Baron G; Weindel K; Herzog C; Marmé D
    Cancer Res; 1997 Dec; 57(23):5421-5. PubMed ID: 9393770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of vascular endothelial growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells.
    Frank S; Stallmeyer B; Kämpfer H; Schaffner C; Pfeilschifter J
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):367-74. PubMed ID: 10024512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hepatic stellate cell contraction during activation in vitro by vascular endothelial growth factor in association with upregulation of FLT tyrosine kinase receptor family, FLT-1.
    Mashiba S; Mochida S; Ishikawa K; Inao M; Matsui A; Ohno A; Ikeda H; Nagoshi S; Shibuya M; Fujiwara K
    Biochem Biophys Res Commun; 1999 May; 258(3):674-8. PubMed ID: 10329444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development.
    Dumont DJ; Fong GH; Puri MC; Gradwohl G; Alitalo K; Breitman ML
    Dev Dyn; 1995 May; 203(1):80-92. PubMed ID: 7647376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localization of vascular endothelial growth factor (VEGF) and its two specific receptors, Flt-1 and KDR, in the porcine placenta and non-pregnant uterus.
    Winther H; Ahmed A; Dantzer V
    Placenta; 1999 Jan; 20(1):35-43. PubMed ID: 9950143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor tyrosine kinase signaling in vascular development.
    Merenmies J; Parada LF; Henkemeyer M
    Cell Growth Differ; 1997 Jan; 8(1):3-10. PubMed ID: 8993829
    [No Abstract]   [Full Text] [Related]  

  • 20. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.
    Millauer B; Shawver LK; Plate KH; Risau W; Ullrich A
    Nature; 1994 Feb; 367(6463):576-9. PubMed ID: 8107827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.